| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | Jun'13 | Jun'12 | Jun'11 | Jun'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||
Net income (loss) | |||||||||
-16,430 | -23,899 | -29,579 | - | -40,209 | - | - | - | - | 2,841 |
Net loss | |||||||||
- | - | - | -25,504 | - | -35,448 | - | - | - | - |
Net loss | |||||||||
- | - | - | - | - | - | -97,361 | -71,350 | -26,657 | - |
Loss from discontinued operations | |||||||||
- | - | - | - | - | - | -19,147 | -7,103 | - | - |
Loss from discontinued operations | |||||||||
- | - | - | - | - | - | - | - | -454 | - |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||
Depreciation and amortization | |||||||||
10,491 | 9,732 | 18,043 | 18,296 | 19,493 | 20,564 | 25,564 | 32,592 | 7,566 | 7,122 |
Impairment of indefinite lived intangible asset | |||||||||
- | - | - | - | - | - | 12,200 | - | - | - |
Share-based compensation | |||||||||
10,601 | 12,289 | 13,629 | 12,638 | 13,930 | 11,313 | 8,216 | 8,458 | 13,365 | 10,232 |
Amortization of debt issuance costs | |||||||||
1,528 | 1,629 | 3,785 | 1,728 | 1,503 | 1,408 | 784 | 363 | - | - |
Amortization and accretion of discount and premium on investments | |||||||||
- | 15 | -67 | -801 | -1,018 | -1,584 | -295 | - | 27 | - |
Loss on sales of investments | |||||||||
- | 171 | - | - | - | - | - | - | - | - |
Realized and unrealized (gain) loss on investments, net | |||||||||
- | - | - | - | - | - | - | - | - | -65 |
Accretion of interest on debt | |||||||||
3,371 | 3,376 | 4,052 | 6,321 | 7,241 | 5,105 | 4,302 | 3,596 | - | - |
Provision for bad debt | |||||||||
3,681 | -73 | 119 | 127 | - | - | - | - | - | - |
Recovery of bad debt, net | |||||||||
- | - | - | - | -14 | -707 | 787 | 1,392 | 239 | -380 |
Provision for write-down of inventories | |||||||||
2,340 | 1,603 | 2,253 | 2,444 | 1,507 | 2,836 | 5,255 | 2,129 | 1,698 | 626 |
Loss on disposal of property and equipment | |||||||||
-2,588 | 8 | -8 | -153 | -62 | -666 | -1,013 | -296 | -312 | -195 |
Loss on extinguishment of debt | |||||||||
- | -3,452 | - | -965 | - | - | - | - | - | - |
Gain on termination of lease obligation | |||||||||
1,007 | - | - | - | - | - | - | - | - | - |
Gain on previously held equity interest in Morphormics | |||||||||
- | - | - | - | - | - | 662 | - | - | - |
Loss from deconsolidation of a variable interest entity | |||||||||
- | - | - | - | - | - | -3,442 | - | - | - |
Provision (benefit) for deferred income taxes | |||||||||
-86 | 30 | -268 | -404 | 664 | 92 | 947 | 495 | 63 | - |
Changes in assets and liabilities: | |||||||||
Restricted cash | |||||||||
- | - | - | - | - | 163 | 1,163 | -1,605 | - | -438 |
Accounts receivable | |||||||||
46,165 | -7,223 | 15,732 | -16,994 | 7,172 | - | - | - | - | - |
Accounts receivable | |||||||||
- | - | - | - | - | 14,786 | -10,858 | 9,162 | -8,698 | 2,448 |
Inventories | |||||||||
14,165 | 8,685 | -7,675 | 10,502 | 21,094 | 8,341 | 5,147 | -11,927 | 4,321 | -244 |
Prepaid expenses and other assets | |||||||||
13,049 | -4,209 | 4,437 | -16 | -1,083 | 5,241 | -4,382 | -2,523 | 1,126 | 4,230 |
Deferred cost of revenue | |||||||||
-531 | -2,422 | -3,321 | -1,452 | -7,776 | 4,875 | 4,005 | -2,080 | -7,586 | -8,980 |
Other assets | |||||||||
- | - | - | - | - | - | - | - | - | 228 |
Accounts payable | |||||||||
9,456 | 2,002 | 2,189 | 2,404 | -1,822 | -1,057 | -1,140 | -21,425 | 10,662 | -5,364 |
Accrued liabilities | |||||||||
10,857 | 1,577 | 8,316 | -1,944 | -8,614 | 21,696 | -18,525 | -10,538 | 9,768 | 4,382 |
Customer advances | |||||||||
-2,549 | 6,189 | -5,158 | - | - | - | - | - | - | - |
Deferred revenues | |||||||||
8,366 | -4,893 | -8,663 | - | - | - | - | - | - | - |
Customer advances | |||||||||
- | - | - | 2,578 | 577 | 1,744 | -659 | -7,044 | -909 | 20 |
Deferred revenues | |||||||||
- | - | - | 2,362 | 9,662 | 3,956 | 3,587 | 20,887 | -14,060 | -27,568 |
Net cash used in operating activities | |||||||||
-29,641 | 18,331 | -380 | 30,925 | -14,409 | - | - | - | - | - |
Cash flows from investing activities | |||||||||
Net cash (used in) provided by operating activities | |||||||||
- | - | - | - | - | 346 | -66,177 | -38,279 | 12,403 | -5,073 |
Purchases of property and equipment | |||||||||
4,311 | 6,276 | 5,031 | 8,066 | 10,445 | 11,931 | 15,126 | 10,769 | 4,022 | 5,130 |
Purchase of intangible asset | |||||||||
- | 333 | 333 | - | - | - | 232 | - | - | - |
Purchases of investments | |||||||||
- | 5,940 | 14,992 | 64,356 | 107,162 | 44,155 | 102,403 | - | 100,710 | 111,429 |
Sales and maturities of investments | |||||||||
- | 30,315 | 38,179 | 80,684 | 121,296 | 64,578 | - | - | 206,414 | 127,086 |
Net cash used in investing activities | |||||||||
-4,311 | 17,766 | 17,823 | 8,262 | 3,689 | - | - | - | - | - |
Cash flows from financing activities | |||||||||
Acquisition of business, net of cash acquired | |||||||||
- | - | - | - | - | - | 3,861 | 1,384 | 70,265 | - |
Net cash provided by (used in) investing activities | |||||||||
- | - | - | - | - | 8,492 | -121,622 | -12,153 | 31,417 | 10,527 |
Proceeds from employee stock plans | |||||||||
3,927 | 4,389 | 3,786 | 3,849 | 6,555 | - | - | - | - | - |
Taxes paid related to net share settlement of equity awards | |||||||||
- | 293 | 1,419 | 2,832 | 660 | 260 | - | - | - | - |
Proceeds from issuance of common stock | |||||||||
- | - | - | - | - | 9,054 | 7,455 | 4,449 | 5,601 | 2,030 |
Payments made to note and loan holders | |||||||||
- | 69,797 | 105,158 | 66,406 | - | 417 | - | - | - | - |
Proceeds from debt, net of costs | |||||||||
19,968 | 66,111 | 48,253 | 64,632 | - | - | 110,462 | 96,100 | - | - |
Borrowings under Revolving Credit Facility, net | |||||||||
4,578 | -27,863 | - | - | - | - | - | - | - | - |
Net cash provided by financing activities | |||||||||
28,473 | -27,453 | -54,538 | -757 | 5,895 | - | - | - | - | - |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||||||
124 | -346 | 197 | -1,006 | - | - | - | - | - | - |
Proceeds from employee stock purchase plan | |||||||||
- | - | - | - | - | - | - | - | - | 1,807 |
Net cash used in financing activities | |||||||||
- | - | - | - | - | 8,377 | 117,917 | 100,549 | 5,601 | 3,837 |
Effect of exchange rate changes on cash and cash equivalents | |||||||||
- | - | - | - | - | 1,818 | -309 | -2,519 | 1,051 | -692 |
Net increase (decrease) in cash and cash equivalents | |||||||||
- | - | - | - | - | 19,033 | -70,191 | - | - | - |
Effect of exchange rate changes on cash and cash equivalents | |||||||||
- | - | - | - | -5,757 | - | - | - | - | - |
Net increase (decrease) in cash, cash equivalents and restricted cash | |||||||||
-5,355 | 8,298 | -36,898 | 37,424 | -10,582 | - | - | - | - | - |
Supplemental schedule of non-cash investing and financing activities: | |||||||||
Net increase in cash and cash equivalent | |||||||||
- | - | - | - | - | - | - | 47,598 | 50,472 | 8,599 |
Cash paid for income taxes | |||||||||
2,191 | 1,460 | 4,458 | 1,026 | 3,184 | - | - | - | - | - |
Cash paid for interest | |||||||||
9,761 | 9,187 | 9,927 | 10,340 | 7,207 | - | - | - | - | - |
Exchange of Convertible Notes | |||||||||
- | 6,641 | - | - | - | - | - | - | - | - |
Modification of Revolving Credit Facility | |||||||||
- | 1,997 | - | - | - | - | - | - | - | - |
Cash paid for income taxes | |||||||||
- | - | - | - | - | 2,499 | 2,000 | 1,198 | 1,392 | 60 |
Cash paid for interest | |||||||||
- | - | - | - | - | 8,208 | 3,750 | 1,875 | - | - |
Exchange of Convertible Notes (Note 13) | |||||||||
- | - | - | - | - | 7,844 | - | 23,189 | - | - |
Unpaid purchase of property and equipment at end of year | |||||||||
235 | 399 | 210 | 218 | 638 | 1,142 | 366 | 389 | - | - |
Unpaid purchase of intangible assets at end of year | |||||||||
- | - | 667 | - | - | - | - | - | - | - |
Transfers from inventory to property and equipment | |||||||||
1,170 | 174 | 1,395 | 1,660 | - | - | - | - | - | - |
Fair value of common stock issued and vested options and restricted stock awards assumed in connection with acquisition of TomoTherapy | |||||||||
- | - | - | - | - | - | - | - | 73,845 | - |